Agile Therapeutics | AGRX - Le Bénéfice D'Exploitation



Le Bénéfice D'Exploitation Changement Date
Adma Biologics USD 50.29M 12.46M 2026-03
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Bayer EUR 827M 2.7B 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Cassava Sciences USD -11.17M 2.38M 2026-03
Cipla INR 8.88B 2.74B 2026-06
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD -9.02M 65.06M 2026-03
CSL USD 2.64B 1.97B 2025-12
Grifols EUR 320.55M 91.01M 2025-12
J&J USD 7.48B 860M 2026-06
Merck USD 840M 2.72B 2026-06
Pacira USD 9.96M 5.33M 2026-06
Pfizer USD 667M 4.32B 2026-06
TherapeuticsMD USD -1.18M 40K 2024-06